Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023

BUY
$241.42 - $282.29 $364,061 - $425,693
1,508 Added 258.22%
2,092 $555,000
Q3 2022

Oct 25, 2022

SELL
$247.06 - $1507.4 $908,686 - $5.54 Million
-3,678 Reduced 86.3%
584 $150,000
Q2 2022

Aug 04, 2022

BUY
$237.11 - $299.66 $195,141 - $246,620
823 Added 23.93%
4,262 $1.08 Million
Q2 2021

Jul 19, 2021

BUY
$225.08 - $271.69 $667,362 - $805,560
2,965 Added 625.53%
3,439 $922,000
Q4 2020

Jan 21, 2021

SELL
$212.5 - $245.46 $36,975 - $42,710
-174 Reduced 26.85%
474 $105,000
Q4 2018

Feb 05, 2019

SELL
$94.85 - $109.54 $36,896 - $42,611
-389 Reduced 37.51%
648 $66,000
Q3 2018

Nov 07, 2018

SELL
$98.13 - $108.9 $334,328 - $371,022
-3,407 Reduced 76.67%
1,037 $112,000
Q3 2017

Oct 17, 2017

BUY
$79.29 - $88.45 $352,364 - $393,071
4,444
4,444 $381,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.